Firmagon Kit
Product Images NDC 55566-8303

Product Visual Gallery

This gallery contains 27 technical images submitted to the FDA as part of the official labeling for Firmagon (NDC 55566-8303). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ferring Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Firmagon 01)

An instructional diagram for FIRMAGON kit showing components for a 240 mg starting dose. It includes two 120 mg vials labeled (a), two syringes labeled (b), two vial adapters labeled (c), injection needles labeled (d), and plunger rods labeled (e). Each component is clearly illustrated and labeled to aid in the preparation and administration of the dose.*

FDA Label Image

Figure (Firmagon 02)

Illustration showing components of the FIRMAGON maintenance dose kit 80 mg, including an 80 mg vial, vial adapter, syringe, injection needle, and plunger rod.*

FDA Label Image

Figure (Firmagon 03)

Illustration showing a setup on a flat surface for the FIRMAGON (Degarelix) kit preparation, featuring labeled components including alcohol pads, gloves, and a sharps disposal container arranged on a table surface.*

FDA Label Image

Figure (Firmagon 04)

An illustration showing a medical preparation setup for FIRMAGON (Degarelix) kit on a table. The image includes syringes with needles, vials, alcohol prep pads, gloves, a sharps disposal container, and other necessary components for administering the medication.*

FDA Label Image

Figure (Firmagon 05)

An instructional illustration showing hands wiping a vial with a swab and then removing the vial cap. The vial is labeled '(o) vial.' This diagram likely demonstrates preparation steps for using the medication FIRMAGON (Degarelix) kit by Ferring Pharmaceuticals Inc.*

FDA Label Image

Figure (Firmagon 06)

An instructional illustration showing the use of a vial adapter for FIRMAGON (Degarelix) kit. The diagram depicts a hand pressing down the vial adapter onto the vial, with an inset demonstrating the removal of a protective seal from the adapter.*

FDA Label Image

Figure (Firmagon 07)

An instructional illustration showing a hand lifting a cap from a vial, likely demonstrating part of the preparation or administration process for FIRMAGON (Degarelix) kit by Ferring Pharmaceuticals Inc.*

FDA Label Image

Figure (Firmagon 08)

An instructional diagram illustrating the assembly of a syringe kit for FIRMAGON (degarelix). The image shows a hand holding a plunger rod being inserted or twisted into the flange of a syringe, which is held by another hand, demonstrating part of the preparation process for use.*

FDA Label Image

Figure (Firmagon 09)

An instructional illustration shows a hand removing the syringe plug from a syringe. A close-up view highlights attaching a Luer lock adapter by twisting it onto the syringe tip. This diagram demonstrates the preparation steps for using a syringe, likely as part of the FIRMAGON kit by Ferring Pharmaceuticals Inc.*

FDA Label Image

Figure (Firmagon 10)

An instructional illustration showing a hand holding a syringe and another hand twisting the cap off a small vial or container, demonstrating the preparation step before using FIRMAGON (Degarelix) kit.*

FDA Label Image

Figure (Firmagon 11)

An instructional illustration showing a hand holding a syringe inserted into a vial, with another hand stabilizing the vial on a flat surface. The image includes a downward arrow indicating the direction of syringe insertion, typical of preparation steps for drug administration.*

FDA Label Image

Figure (Firmagon 12)

An instructional illustration showing a gloved hand holding a syringe above a vial, with an arrow indicating a twisting motion to secure or detach the syringe from the vial. This image is likely part of preparation instructions for administering FIRMAGON (Degarelix) kit.*

FDA Label Image

Figure (Firmagon 13)

An instructional illustration shows a gloved hand holding a syringe while pulling down the plunger. A black arrow points downward, indicating the direction of plunger movement, likely to remove air or prepare the syringe for injection.*

FDA Label Image

Figure (Firmagon 14)

An instructional illustration depicting two hands preparing a syringe. One hand holds the syringe barrel, while the other hand is unscrewing or attaching the cap or needle, indicated by a curved arrow pointing counterclockwise. This image is likely part of usage or administration instructions for the FIRMAGON kit by Ferring Pharmaceuticals Inc.*

FDA Label Image

Figure (Firmagon 15)

Instructional illustration showing hands preparing an injection for FIRMAGON (Degarelix) KIT, with a labeled injection needle being attached or removed from a syringe. The image demonstrates part of the injection preparation process.*

FDA Label Image

Figure (Firmagon 16)

An instructional illustration showing a gloved hand applying four square patches arranged in a 2x2 grid to a person's lower back. This likely demonstrates proper placement of transdermal patches or application technique for a drug delivery system.*

FDA Label Image

Figure (Firmagon 17)

An instructional illustration showing a hand removing the needle shield labeled as (w) from a syringe with a needle. The needle cover is labeled as (x) and is being pulled away from the syringe. The image demonstrates how to expose the needle prior to injection.*

FDA Label Image

Figure (Firmagon 18)

Instructional diagram showing two hands preparing a syringe, with an inset illustrating the needle insertion angle of greater than 45 degrees into tissue. A timer indicating 30 seconds is shown next to the hands, suggesting a timed step in the process. This illustration is related to the use or administration of the FIRMAGON (Degarelix) kit.*

FDA Label Image

Figure (Firmagon 19)

An instructional illustration showing a close-up of a person's hands preparing a syringe by pulling back the plunger, likely as part of a medication administration process. The person is wearing a wristwatch, and an arrow indicates the direction of plunger movement.*

FDA Label Image

Figure (Firmagon 20)

An instructional illustration showing a hand holding a device at a 45-degree angle, demonstrating how to position it for use. The image includes an arrow indicating a downward motion, likely guiding the user on how to operate or activate the device.*

FDA Label Image

Figure (Firmagon 21)

An instructional diagram illustrating a medical device component labeled as a '(y) lock.' The illustration appears to show part of an injection or delivery system, possibly a needle or catheter assembly, with labeled elements for user guidance.*

FDA Label Image

Figure (Firmagon 22)

An illustration showing two men facing each other, one wearing a suit and extending his hand as if to shake hands with the other man, who is casually dressed in a T-shirt. The image appears instructional or conversational in nature.*

FDA Label Image

Chemical Structure (Firmagon 23)

Chemical structure of Degarelix, the active ingredient in FIRMAGON. The diagram depicts the molecular structure including peptide chains, functional groups, and specific bonding arrangements, with an annotation indicating x equals 1 to 2 acetate ions.*

FDA Label Image

Figure 1 (Firmagon 24)

A line graph plotting levels of a substance (ng/dL) over time since the first dose in days, showing a sharp initial decline followed by a stable low level over nearly one year. The graph includes error bars at each time point, indicating variability around the mean values.*

FDA Label Image

Figure 2 (Firmagon 25)

A line graph showing percentage change in testosterone levels over 28 days following the first dose. It compares three treatments: Degarelix 240/160 mg (dotted line), Degarelix 240/80 mg (pink line), and Lupron Depot 7.5 mg (solid blue line). The x-axis represents days since first dose, the y-axis shows percentage change with error bars.*

FDA Label Image

Principal Display Panel (240 mg Kit Carton)

FIRMAGON 240 mg (degarelix for injection) kit packaging label from Ferring Pharmaceuticals Inc. The label indicates a 240 mg dose administered from two vials each containing 120 mg. It includes a description of kit contents such as vials with powder for injection, syringes with sterile water for injection, vial adapters, and administration needles. The label also features dosage instructions for single-use subcutaneous injection and various regulatory labeling details including barcode and NDC 55566-8403-1.*

FDA Label Image

Principal Display Panel (80 mg Kit Carton)

Packaging label for FIRMAGON 80 mg kit, containing degarelix for injection. The label shows Ferring Pharmaceuticals Inc. as the manufacturer. It specifies the kit contents including one vial with 80 mg powder for injection, one syringe with sterile water for reconstitution/administration, one vial adapter, and one administration needle. The label indicates the product is for single use subcutaneous injection and mentions a maintenance dose for 28 days.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.